What Drives Fatigue in Psoriasis and PsA?
Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.
Stay updated with breaking news from Alexander Egeberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.
Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.
BALLERUP, Denmark, October 09, 2023--Globally known professor and dermatologist joins LEO Pharma
Psoriasis wasn't associated with higher risk of heart attacks or strokes when people with the skin condition didn't have a family history of cardiovascular disease, the study found.
A set of highlights from some of the impactful breakthroughs covered in dermatology this past month, including phase 3 trial data bimekizumab, tapinarof, and other treatments.